XENETIC BIOSCIENCES, INC. Interest Income, Other
XENETIC BIOSCIENCES, INC. (XBIO) reported Interest Income, Other of $16.54 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-30.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2018-03-30
- XENETIC BIOSCIENCES, INC. interest income, other for the quarter ending 2017-12-31 was $6.34K, a 634200.00% increase year-over-year.
- XENETIC BIOSCIENCES, INC. interest income, other for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. interest income, other for the quarter ending 2017-06-30 was $10.20K, a 78369.23% increase year-over-year.
- XENETIC BIOSCIENCES, INC. interest income, other for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. interest income, other for fiscal 2017 was $16.54K, a 51600.00% increase from fiscal 2016.
- XENETIC BIOSCIENCES, INC. interest income, other for fiscal 2016 was $32.00, a 98.11% decline from fiscal 2015.
- XENETIC BIOSCIENCES, INC. interest income, other for fiscal 2015 was $1.69K, a 91.06% decline from fiscal 2014.
- XENETIC BIOSCIENCES, INC. interest income, other for fiscal 2014 was $18.96K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2017-12-31 | $6.34K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $6.34K derived: sum of 2 quarters · filed 2018-03-30 | $16.54K derived: sum of 3 quarters · filed 2018-03-30 | $16.54K 10-K · filed 2018-03-30 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | $10.20K derived: sum of 2 quarters · filed 2017-11-14 | $10.20K 10-Q · filed 2017-11-14 | $10.20K derived: sum of 4 quarters · filed 2018-03-30 |
| 2017-06-30 | $10.20K 10-Q · filed 2017-08-14 | $10.20K 10-Q · filed 2017-08-14 | $10.20K derived: sum of 3 quarters · filed 2018-03-30 | $10.21K derived: sum of 4 quarters · filed 2018-03-30 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $1.00 derived: sum of 2 quarters · filed 2018-03-30 | $5.00 derived: sum of 3 quarters · filed 2018-03-30 | $18.00 derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $5.00 derived: sum of 2 quarters · filed 2018-03-30 | $18.00 derived: sum of 3 quarters · filed 2018-03-30 | $32.00 10-K · filed 2018-03-30 |
| 2016-09-30 | $4.00 10-Q · filed 2017-11-14 | $17.00 derived: sum of 2 quarters · filed 2017-11-14 | $31.00 10-Q · filed 2017-11-14 | $570.00 derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $13.00 10-Q · filed 2017-08-14 | $27.00 10-Q · filed 2017-08-14 | $566.00 derived: sum of 3 quarters · filed 2017-08-14 | $633.00 derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $14.00 10-Q · filed 2017-05-15 | $553.00 derived: sum of 2 quarters · filed 2017-05-15 | $620.00 derived: sum of 3 quarters · filed 2017-05-15 | $1.53K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $539.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $606.00 derived: sum of 2 quarters · filed 2017-03-31 | $1.52K derived: sum of 3 quarters · filed 2017-03-31 | $1.69K 10-K · filed 2017-03-31 |
| 2015-09-30 | $67.00 10-Q · filed 2016-11-14 | $981.00 derived: sum of 2 quarters · filed 2016-11-14 | $1.16K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $914.00 10-Q · filed 2016-08-15 | $1.09K 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $174.00 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | $18.96K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |